Stock News Alerts, Breaking News Alerts, Indexed Releases, Ticker Tagging, Investor Outreach, Video Press Releases, Stock Newsletters, Social Media Coverage, News Dissemination Services

Follow Us on Facebook   Follow Us on Twitter   Follow Us on You Tube   Follow Us on Linked In   Subscribe To Our Feed
image image

$SHRK News - SharkReach, Inc. Reaches Agreement To Acquire Key

headline

HERMOSA BEACH, California, - (http://www.financialnewsmedia.com News Alert) - SharkReach, Inc. ("SharkReach(R)" or the "Company") (OTC Markets: SHRK) a millennial influence marketing company today announced that it has reached an agreement to acquire 100% of a key strategic partner in the millennial social media marketplace.

Under the terms of the agreement, at Closing the Company will acquire 100% of The Mobile Media Lab, LLC for...read more

Company: SharkReach, Inc. (OTC: SHRK)
Symbol:

image image

$PSID News - PositiveID Corporation's Thermomedics' Subsidiary Signs Deals with Five New Healthcare Products Distributors in January

$PSID News - PositiveID Corporation's Thermomedics' Subsidiary Signs Deals with Five New Healthcare Products Distributors in JanuaryDELRAY BEACH, Florida, - (http://www.financialnewsmedia.com News Alert) - PositiveID Corporation (OTCQB: PSID) ("PositiveID" or "Company"), a life sciences company focused on detection and diagnostics, announced today that its Thermomedics subsidiary, which markets the Caregiver® FDA-cleared...read more

$INCT News - Qwote and Bahja Rodriquez Sign With Play Celebrity Games for Production of Game Apps

$INCT News - Qwote and Bahja Rodriquez Sign With Play Celebrity Games for Production of Game AppsStimulating Software Launches Five New Mobile Game Apps - SAN DIEGO CA - (http://www.financialnewsmedia.com News Alert) - InCapta, Inc. (OTC: INCT), and its subsidiaries Play Celebrity Games and Stimulating Software, announce that Qwote and Bahja...read more

$AMBS Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia

$AMBS Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced DyskinesiaSAN FRANCISCO, - (http://www.financialnewsmedia.com News Alert) - Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced that it has received orphan drug...read more

$MINE Breaking News - Minerco's Athena Brands Completes Acquisition of VitaminFIZ(R)

$MINE Breaking News - Minerco's Athena Brands Completes Acquisition of VitaminFIZ(R)VitaminFIZZ to Expand with Additional Flavors and Functionality - HOUSTON, Texas, - (http://www.financialnewsmedia.com News Alert) - Minerco, Inc. (OTC:MINE), parent company of Athena Brands, Inc., announced the completion of the acquisition of VitaminFIZZ(R), the vitamin...read more

View All Featured News

RECENT FNM NEWS COVERAGE

FNM VIDEO PRESS RELEASES

1/10/2013
Ticker: GROV
Final Snapshot:
Market Cap: 
Outstandg. Shares: 
Recent Close: 
11/12/2012
Ticker: PZOO
Final Snapshot:
Market Cap: 
Outstandg. Shares: 
Recent Close: 
10/23/2012
Ticker: ZYCI
Final Snapshot:
Market Cap: 
Outstandg. Shares: 
Recent Close: 
10/4/2012
Ticker: PZOO
Final Snapshot:
Market Cap: 
Outstandg. Shares: 
Recent Close: 
9/17/2012
Ticker: PZOO
Final Snapshot:
Market Cap: 
Outstandg. Shares: 
Recent Close: 
 
© 2015 FinancialNewsMedia.com. All Rights Reserved. Created, Designed, Owned & Operated by FN Media Group, LLC.
Follow Us on Facebook   Follow Us on Twitter   Follow Us on You Tube   Follow Us on Linked In   Subscribe To Our Feed
 
FinancialNewsMedia.com (FNM) is a third party publisher and news disemmination solutions provider of multimedia platforms that enable officers & directors, corporate communicators, public relations and investor relations officers to leverage content to engage with all their key audiences. Any ideas and opinions presented in any FNM News Alerts, Video clips, Press Releases, RSS Feeds or Social Network Posts are for informational purposes only, and do not reflect the opinions of FNM or any of its affiliates, subsidiaries or partners. UNDER NO CIRCUMSTANCES SHOULD ANY CONTENT CONTAINED HEREIN BE INTERPRETED TO REPRESENT TRADING OR INVESTMENT ADVICE. All viewers agree that under no circumstances will FNM, its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information contained on this or any affiliated website. Read Full Disclaimer.